Clinical trial
Prospective, National and Multicenter Biomedical Study of Cohorts, Aimed at Patients With Surgical Indication of Hysterectomy, Laparoscopic or Laparotomic Myomectomy Due to Diagnosis of Myometrial Tumors (Leiomyoma / Leiomyosarcoma)
NCT04214457 is registered in ClinicalTrials.gov with Igenomix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, National and Multicenter Biomedical Study of Cohorts, Aimed at Patients With Surgical Indication of Hysterectomy, Laparoscopic or Laparotomic Myomectomy Due to Diagnosis of Myometrial Tumors (Leiomyoma / Leiomyosarcoma)
- Lead sponsor
- Igenomix
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 20, 2019
- Completion date
- July 31, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.